Condition
Multiple Sclerosis Relapse clinical trials and research
Research outlook What's coming for Multiple sclerosis: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 2 Multiple Sclerosis Relapse clinical trials that are recruiting, at sites in 2 countries (most in Greece (1), United States (1)). By phase: Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Assessing the effects of Clemastine Fumarate on myelin repair in MS patients
This study is testing if a medication called Clemastine Fumarate can help repair the protective covering of nerves in people with relapsing-remitting multiple sclerosis.
-
Monitoring relapses in MS patients after surgery
This study looks at how surgery and anesthesia might affect the chances of relapse in people with Multiple Sclerosis during the year after their operation.
Related topics
Quick answers
How many Multiple Sclerosis Relapse clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Greece (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.